Geode Capital Management
ROIV icon

Geode Capital Management’s Roivant Sciences ROIV Stock Holding History

Geode Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426M Buy
11,674,380
+1,491,903
+15% +$44.1M 0.02% 511
2026
Q1 		$282M Buy
10,182,477
+2,028,931
+25% +$52.1M 0.02% 608
2025
Q4 		$177M Sell
8,153,546
-49,048
-0.6% -$968K 0.01% 766
2025
Q3 		$124M Buy
8,202,594
+452,195
+6% +$5.6M 0.01% 940
2025
Q2 		$87.4M Sell
7,750,399
-216,986
-3% -$2.35M 0.01% 1105
2025
Q1 		$80.4M Buy
7,967,385
+195,554
+3% +$2.11M 0.01% 1102
2024
Q4 		$92M Buy
7,771,831
+26,727
+0.3% +$316K 0.01% 1063
2024
Q3 		$89.4M Buy
7,745,104
+1,460,205
+23% +$16.6M 0.01% 1065
2024
Q2 		$66.4M Buy
6,284,899
+238,053
+4% +$2.61M 0.01% 1167
2024
Q1 		$63.7M Buy
6,046,846
+522,270
+9% +$5.63M 0.01% 1186
2023
Q4 		$62.1M Buy
5,524,576
+306,396
+6% +$2.99M 0.01% 1202
2023
Q3 		$61M Buy
5,218,180
+2,478,175
+90% +$28M 0.01% 1097
2023
Q2 		$27.6M Buy
2,740,005
+1,118,562
+69% +$10M ﹤0.01% 1643
2023
Q1 		$12M Buy
1,621,443
+95,750
+6% +$788K ﹤0.01% 2139
2022
Q4 		$12.2M Buy
1,525,693
+81,607
+6% +$454K ﹤0.01% 2123
2022
Q3 		$4.65M Buy
1,444,086
+59,614
+4% +$231K ﹤0.01% 2720
2022
Q2 		$5.63M Buy
1,384,472
+94,293
+7% +$374K ﹤0.01% 2638
2022
Q1 		$6.37M Buy
1,290,179
+130,042
+11% +$858K ﹤0.01% 2648
2021
Q4 		$11.7M Buy
+1,160,137
New +$9.65M ﹤0.01% 2344

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management's ROIV Position: Q2 2026 in Review

Geode Capital Management increased its Roivant Sciences (ROIV) stake by 15% in Q2 2026, buying an estimated $44.1M and bringing the position to 11,674,380 shares worth $426M. The position accounts for 0.02% of the portfolio, ranked #511.

Geode Capital Management first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Geode Capital Management held 11,674,380 shares of Roivant Sciences worth $426M as of Q2 2026.
  • Geode Capital Management bought 1,491,903 Roivant Sciences shares in Q2 2026, an estimated $44.1M.
  • Roivant Sciences made up 0.02% of Geode Capital Management's portfolio in Q2 2026, its #511 holding.
  • Geode Capital Management first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.